Cargando…
Enhanced electrocardiographic monitoring of patients with Coronavirus Disease 2019
BACKGROUND: Many of the drugs being used in the treatment of the ongoing pandemic coronavirus disease 2019 (COVID-19) are associated with QT prolongation. Expert guidance supports electrocardiographic (ECG) monitoring to optimize patient safety. OBJECTIVE: The purpose of this study was to establish...
Autores principales: | Jain, Shashank, Workman, Virginia, Ganeshan, Raj, Obasare, Edinrin R., Burr, Alicia, DeBiasi, Ralph M., Freeman, James V., Akar, Joseph, Lampert, Rachel, Rosenfeld, Lynda E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Heart Rhythm Society.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200355/ https://www.ncbi.nlm.nih.gov/pubmed/32387247 http://dx.doi.org/10.1016/j.hrthm.2020.04.047 |
Ejemplares similares
-
Risk of COVID-19 infection after cardiac electrophysiology procedures
por: Workman, Virginia, et al.
Publicado: (2020) -
Real world utilization and impact of the wearable cardioverter-defibrillator in a community setting
por: Naniwadekar, Aditi, et al.
Publicado: (2017) -
Severe Acute Respiratory Syndrome-Coronavirus-2 Effects at the Maternal-Fetal Interface
por: DeBiasi, Roberta L
Publicado: (2022) -
The electrocardiographic manifestations and derangements of 2019 novel coronavirus disease (COVID-19)
por: Singh, Aniruddha, et al.
Publicado: (2021) -
Surface electrocardiographic characteristics in coronavirus disease 2019: repolarization abnormalities associated with cardiac involvement
por: Chen, Liang, et al.
Publicado: (2020)